vialroom

#cagrilintide 2025-10-18

Saturday19 messages5 participantstimes are UTC
Highlights from this day
  • mag_citrate — is the nausea profile genuinely different or am i imagining it 21:28
  • point_two_five — the fullness thing is the part people describe differently, food stops being interesting rather than repellent the numbers everyone quotes come from the combination,… 21:38
  • tokyo_taper — the fullness effect hasnt faded over 6 months, unlike my semaglutide appetite curve 21:51
  • tokyo_taper — the slower titration in here is community habit as much as anything, the trials had their own schedule, not advice obviously 21:52
MC

update on the earlier thing i was sceptical about monotherapy and after 14 months im still sceptical, just less so

MC

update on the earlier thing is the weekly schedule the same here

MC

i titrated over twice as many weeks as i did on semaglutide and that was right for me

MM

10 in 0.5ml gives 2mg/ml which is what i use, purely because the units come out round

MC

is the nausea profile genuinely different or am i imagining it

😂15🧊10

£38 for a 10 vial and it lasts me longer than the GLP-1 does at my doses

the fullness thing is the part people describe differently, food stops being interesting rather than repellent
the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair

🎉1

does amylin do something about fullness that the GLP-1 doesnt

TT

the fullness effect hasnt faded over 6 months, unlike my semaglutide appetite curve

⚠️2👀1🤝18

the slower titration in here is community habit as much as anything, the trials had their own schedule, not advice obviously

Cited study
Efficacy and Safety of Cagrilintide in Adults with Overweight or Obesity — Phase 2
The Lancet · 2021
Cagrilintide monotherapy, dose ranging. The combination trials came later.
TT

ok so added it to an existing semaglutide dose rather than starting both, which made attribution possible, ymmv

anyone got two Medutest results on the same ERP lot for this